Clinical Trial Update: Mode Selection Trial in Sinus Node Dysfunction (MOST) [Phase 3]

View source ↗

Summary

The Mode Selection Trial in Sinus Node Dysfunction (MOST) is a Phase 3 study that has completed enrollment/status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Arrhythmia
• Cardiovascular Disease
• Heart Disease
• Sick Sinus Syndrome
• Stroke
• Vascular Disease

Snippet

Sponsor: Mt. Sinai Medical Center, Miami | Conditions: Arrhythmia, Cardiovascular Diseases | Phase 3 | Status: COMPLETED